Amir Kalali
Fortune : 21 137 $ au 31/05/2026
Fortune : 21 137 $ au 31/05/2026
Amir H.
Kalali is the founder of Decentralized Trials & Research Alliance.
Current positions include Chairman at Cns Summit, Director at Tikvah Therapeutics, Inc., Director at Neuroscience Education Institute, Independent Director at Atai Beckley, Inc. since 2021, Vice President-Medical & Scientific Services at Quintiles, Inc. (California), Professor at the University of California San Diego, and Executive Secretary at the International Society for CNS Drug Development.
Former roles include Director at Cypress Bioscience, Inc. from 2004 to 2011, Director at Dthera Sciences from 2018 to 2020, Global Head-Neuroscience Center Excellence at IQVIA, Inc. from 1997 to 2017, and Member-Supervisory Board at Atai Beckley NV.
Education includes a doctorate from the University of London.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0 % | 04/06/2026 | 4 666 ( 0 % ) | 21 137 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Directeur Technique/Scientifique/R&D | - |
Neuroscience Education Institute
Neuroscience Education Institute Internet Software/ServicesTechnology Services Operates as a library of online education | Directeur/Membre du Conseil | - |
Tikvah Therapeutics, Inc.
Tikvah Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutic products | Directeur/Membre du Conseil | - |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
International Society for CNS Drug Development
International Society for CNS Drug Development Miscellaneous Commercial ServicesCommercial Services The International Society for CNS Drug Development (ISCDD) is a non-profit independent society that focuses on addressing scientific challenges in CNS drug development. The company achieves this through research and collaboration among stakeholders, including academia, industry, and government. The company is based in San Diego, CA. | Secrétaire Général | - |
Cns Summit
Cns Summit Miscellaneous Commercial ServicesCommercial Services Provides advanced clinical development services | Président | - |
Decentralized Trials & Research Alliance | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
| DTHERA SCIENCES | Directeur/Membre du Conseil | 01/06/2020 |
| IMS HEALTH, INC. | Corporate Officer/Principal | 01/01/2017 |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 12 |
|---|---|
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Develops drugs, diagnostics and other therapeutic products | Health Technology |
IQVIA, Inc.
IQVIA, Inc. Packaged SoftwareTechnology Services Provides AI assistant, analytics and clinical research services for healthcare sector | Technology Services |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
Tikvah Therapeutics, Inc.
Tikvah Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutic products | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neuroscience Education Institute
Neuroscience Education Institute Internet Software/ServicesTechnology Services Operates as a library of online education | Technology Services |
International Society for CNS Drug Development
International Society for CNS Drug Development Miscellaneous Commercial ServicesCommercial Services The International Society for CNS Drug Development (ISCDD) is a non-profit independent society that focuses on addressing scientific challenges in CNS drug development. The company achieves this through research and collaboration among stakeholders, including academia, industry, and government. The company is based in San Diego, CA. | Commercial Services |
Dthera Sciences
Dthera Sciences Packaged SoftwareTechnology Services Develops digital therapeutic technology | Technology Services |
Cns Summit
Cns Summit Miscellaneous Commercial ServicesCommercial Services Provides advanced clinical development services | Commercial Services |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Decentralized Trials & Research Alliance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national